Effects of Linagliptin in Addition to Empagliflozin on Islet Cell Physiology
Clinical trial NCT02401880 · COMPLETED
Trial details
- NCT number
- NCT02401880
- Sponsor
- Profil Institut für Stoffwechselforschung GmbH
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-01
- Primary completion
- 2015-12-01
- Enrollment
- 89
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.